» Articles » PMID: 37255536

The Fusiform Gyrus Exhibits Differential Gene-gene Co-expression in Alzheimer's Disease

Overview
Specialty Geriatrics
Date 2023 May 31
PMID 37255536
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's Disease (AD) is an irreversible neurodegenerative disease clinically characterized by the presence of β-amyloid plaques and tau deposits in various regions of the brain. However, the underlying factors that contribute to the development of AD remain unclear. Recently, the fusiform gyrus has been identified as a critical brain region associated with mild cognitive impairment, which may increase the risk of AD development. In our study, we performed gene co-expression and differential co-expression network analyses, as well as gene-expression-based prediction, using RNA-seq transcriptome data from post-mortem fusiform gyrus tissue samples collected from both cognitively healthy individuals and those with AD. We accessed differential co-expression networks in large cohorts such as ROSMAP, MSBB, and Mayo, and conducted over-representation analyses of gene pathways and gene ontology. Our results comprise four exclusive gene hubs in co-expression modules of Alzheimer's Disease, including , and . Further, we identified three genes with differential co-expressed links, namely , and . The differential co-expressed network showed moderate predictive performance for AD, with an area under the curve ranging from 0.71 to 0.76 (+/- 0.07). The over-representation analysis identified enrichment for Toll-Like Receptors Cascades and signaling pathways, such as G protein events, hydrolysis and mechanism, in the fusiform gyrus. In conclusion, our findings shed new light on the molecular pathophysiology of AD by identifying new genes and biological pathways involved, emphasizing the crucial role of gene regulatory networks in the fusiform gyrus.

Citing Articles

pathogenic variant: genomic-phenotypic analysis.

Bamaga A, Muthaffar O, Alyazidi A, Bahowarth S, Shawli M, Alotibi F J Med Life. 2024; 17(5):500-507.

PMID: 39144687 PMC: 11320618. DOI: 10.25122/jml-2024-0065.


Identification of deregulated lncRNAs in Alzheimer's disease: an integrated gene co-expression network analysis of hippocampus and fusiform gyrus RNA-seq datasets.

Filomena E, Picardi E, Tullo A, Pesole G, DErchia A Front Aging Neurosci. 2024; 16:1437278.

PMID: 39086756 PMC: 11288953. DOI: 10.3389/fnagi.2024.1437278.


Dissecting the Puzzling Roles of FAM46C: A Multifaceted Pan-Cancer Tumour Suppressor with Increasing Clinical Relevance.

Lai G, De Grossi F, Catusi I, Pesce E, Manfrini N Cancers (Basel). 2024; 16(9).

PMID: 38730656 PMC: 11083040. DOI: 10.3390/cancers16091706.

References
1.
Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

2.
Ramirez A, de Hoz R, Salobrar-Garcia E, Salazar J, Rojas B, Ajoy D . The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma. Front Aging Neurosci. 2017; 9:214. PMC: 5498525. DOI: 10.3389/fnagi.2017.00214. View

3.
Kania A, Klein R . Mechanisms of ephrin-Eph signalling in development, physiology and disease. Nat Rev Mol Cell Biol. 2016; 17(4):240-56. DOI: 10.1038/nrm.2015.16. View

4.
Mostafavi S, Gaiteri C, Sullivan S, White C, Tasaki S, Xu J . A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018; 21(6):811-819. PMC: 6599633. DOI: 10.1038/s41593-018-0154-9. View

5.
Brito L, Ribeiro-Dos-Santos A, Vidal A, de Araujo G . Differential Expression and miRNA-Gene Interactions in Early and Late Mild Cognitive Impairment. Biology (Basel). 2020; 9(9). PMC: 7565463. DOI: 10.3390/biology9090251. View